or Try an Advanced Search...

    Technical Analysis for AKRO - Akero Therapeutics, Inc.

    Grade Last Price % Change Price Change
    F 20.43 -3.06% -0.65
    AKRO closed up 3.79 percent on Wednesday, May 15, 2024, on 48 percent of normal volume.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical AKRO trend table...
    Date Alert Name Type % Chg
    Crossed Above 20 DMA Bullish -3.06%
    Gapped Up Strength -3.06%
    Fell Below 20 DMA Bearish 0.62%
    Earnings Movers Other 0.62%
    Gapped Up Strength 0.62%
    Crossed Above 20 DMA Bullish -0.95%
    Earnings Movers Other -0.95%
    Multiple of Ten Bullish Other -0.95%
    Outside Day Range Expansion -0.95%
    Fell Below 20 DMA Bearish 3.94%
    Older End-of-Day Signals for AKRO ...

       Recent Intraday Alerts

    Alert Time
    20 DMA Support 8 minutes ago
    Down 3% 8 minutes ago
    60 Minute Opening Range Breakdown 20 minutes ago
    Fell Below Previous Day's Low 27 minutes ago
    Possible NR7 about 1 hour ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    AKRO Chart by TradingView
    Basic chart:

    Profile

    Akero Therapeutics is a clinical-stage biotechnology company focused on the development and commercialization of transformative treatments for patients with serious metabolic diseases with high unmet medical need. The company's lead program AKR-001 is being evaluated in a Phase 2a clinical trial for the treatment of non-alcoholic steatohepatitis (NASH).
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Alcohol Clinical Trial Hepatitis Steatohepatitis Metabolic Disease Non Alcoholic Fatty Liver Disease

    Is AKRO a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 13 Akero Therapeutics Inc (AKRO) Q1 2024 Earnings: Misses Analyst Forecast Amid Continued ...
    May 10 Akero Therapeutics GAAP EPS of -$0.90 beats by $0.05
    May 10 Akero Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
    May 8 Akero Therapeutics to Present at the BofA Securities 2024 Health Care Conference
    Apr 30 Akero Therapeutics names Scott Gangloff as CTO
    Apr 30 Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer
    Apr 3 Akero Therapeutics' EFX Data Warrants Caution
    Mar 20 Billionaire Steve Cohen and Insiders Are Buying These 10 Stocks
    Mar 18 Ozempic Can’t Do It All—A Potential New Blockbuster Is a Reminder of That
    Mar 15 Madrigal (MDGL) Stock Up as FDA Approves First Drug for NASH
    See more AKRO news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 58.38
    52 Week Low 11.25
    Average Volume 1,074,560
    200-Day Moving Average 27.32
    50-Day Moving Average 23.26
    20-Day Moving Average 20.43
    10-Day Moving Average 20.70
    Average True Range 1.32
    RSI (14) 48.98
    ADX 29.03
    +DI 12.85
    -DI 21.75
    Chandelier Exit (Long, 3 ATRs) 18.30
    Chandelier Exit (Short, 3 ATRs) 22.16
    Upper Bollinger Bands 22.00
    Lower Bollinger Band 18.85
    Percent B (%b) 0.7
    BandWidth 15.43
    MACD Line -0.53
    MACD Signal Line -0.74
    MACD Histogram 0.2076
    Fundamentals Value
    Market Cap 1.17 Billion
    Num Shares 55.7 Million
    EPS -2.29
    Price-to-Earnings (P/E) Ratio -9.20
    Price-to-Sales 0.00
    Price-to-Book 1.89
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 22.95
    Resistance 3 (R3) 22.96 22.35 22.63
    Resistance 2 (R2) 22.35 21.87 22.34 22.53
    Resistance 1 (R1) 21.71 21.58 21.41 21.70 22.42
    Pivot Point 21.10 21.10 20.95 21.09 21.10
    Support 1 (S1) 20.46 20.62 20.16 20.45 19.72
    Support 2 (S2) 19.85 20.33 19.84 19.61
    Support 3 (S3) 19.21 19.85 19.51
    Support 4 (S4) 19.20